In addition, we evaluated the effect of TAM inhibitors and Nintedanib in the presence or absence of TGF-β on HPF and IPF FB migration using a scratch assay [42,43]. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.